Case Filed: Mar 12, 2012
Case Closed: May 10, 2013
Judge: Barbara M.G. Lynn
Court: Texas Northern District Court
Case Summary:
MES accused HTC, AT&T,
Sprint, Verizon and Celco of infringing 4 patents related to the transmission
of data to and from mobile phones. The patents involved in this suit are:
- US6415325 - Transmission system with improved synchronization, issued on July 02, 2002 and expires* by Dec 16, 2017
- US6879838 - Distributed location based service system, issued on Apr 12, 2005 and expires* by Apr 20, 2021
- US7096033 - Mobile apparatus enabling inter-network communication, issued on Aug 22, 2006 and expires* by Jul 18, 2020
- US7317687 - Transmitting data frames with less interframe space (ifs) time, issued on Jan 08, 2008 and expires* by Jul 13, 2024
The patents are currently
assigned[i]
to MES (source: MaxVal’s Assignment
Database). MES alleged that defendants
are manufacturing and commercializing HTC devices including HTC Inspire, HTC
Status and HTC Vivid that are configurable to communicate data received from a
first communication network to a second communication network as claimed in the
above said patents.
The
dispute has reached an end with MES filing motion to dismiss all the claims. Upon
MES’s request, the Court ordered all the claims and counterclaims be dismissed without
prejudice, thereby concluding the case. However, another case filed by MES
against Motorola Mobility asserting the same patents is still pending.
See 3:12-cv-00794
for more details. To get alerts on cases filed/closed, subscribe to our Litigation Alerts.
Has
this patent been litigated? Use our free tool or
download our free Android/iOS app on Google Play/ App Store.
* Expected expiration date.
Patent Term
Estimator is a free
web-based tool that automatically calculates patent terms and expiration dates
for U.S. utility patents.
[i] MaxVal offers Patent Assignment Alert service where subscribers
receive email alerts when assignments relating to target applications, patents
or entities of interest are recorded.
No comments:
Post a Comment